National Institute of Allergy and Infectious Diseases; Notice of Meetings, 55054-55055 [2023-17398]
Download as PDF
<![CDATA[
55054
Federal Register / Vol. 88, No. 155 / Monday, August 14, 2023 / Notices
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm.
(Authority: 44 U.S.C. 3101.)
Dated: August 9, 2023.
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023–17379 Filed 8–11–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–4040–0010]
Agency Information Collection
Request; 60-Day Public Comment
Request
AGENCY:
ACTION:
Submit your comments to
sagal.musa@hhs.gov or by calling (202)
205–2634.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 4040–0010–60D
and project title for reference, to Sagal
Musa, email: sagal.musa@hhs.gov, or
call (202) 205–2634 the Reports
Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Project/
Performance Site Location(s), Project
Abstract, and Key Contacts forms.
Type of Collection: Revision.
OMB No.: 4040–0010.
Abstract: The Project/Performance
Site Location(s), Project Abstract, and
Key Contacts forms provide the Federal
ADDRESSES:
Office of the Secretary, HHS.
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
SUMMARY:
Comments on the ICR must be
received on or before October 13, 2023.
DATES:
grant-making agencies an alternative to
the Standard Form 424 data set and
form. Agencies may use Project/
Performance Site Location(s), Project
Abstract, and Key Contacts forms for
grant programs not required to collect
all the data that is required on the SF–
424 core data set and form. Project/
Performance Site Location(s), Project
Abstract, and Key Contacts forms are
used by organizations to apply for
Federal financial assistance in the form
of grants. This form is submitted to the
Federal grant-making agencies for
evaluation and review. Previously, 26
Federal grant-making entities were
using this information collection. This
information collection will now be
utilized by 51 Federal grant-making
agencies and additional grant-making
entities. To improve the transparency of
reading and enhance user-friendliness
of the supporting statement A, language
modifications were implemented within
sections 3 through 16. For section 14,
Cost to the Federal Government was
adjusted to the 2023 base general
schedule.Grants.gov is requesting a
revision of this collection to allow for
data reporting and publication by
agencies requesting to use the common
form. The information collection (IC)
expires on November 30, 2025.
Grants.gov seeks a three-year clearance
of these collections.
ANNUALIZED BURDEN HOUR TABLE
Number of
responses per
respondents
Average
burden per
response
Total burden
hours
Respondents (if necessary)
Project/Performance
Site
Location(s).
Project Abstract ..............................
Key Contacts ..................................
Grant Applicants .............................
127,281
1
1
127,281
Grant Applicants .............................
Grant Applicants .............................
230
4,566
1
1
1
1
230
4,566
Total .........................................
.........................................................
132,077
1
1
132,077
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–17395 Filed 8–11–23; 8:45 am]
BILLING CODE 4150–AE–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Forms (if necessary)
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
VerDate Sep<11>2014
17:38 Aug 11, 2023
Jkt 259001
meetings of the National Advisory
Allergy and Infectious Diseases Council.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: September 11, 2023.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Acting
Director.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Grand Hall, 5601
Fishers Lane, MD 20852 (Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
E:\FR\FM\14AUN1.SGM
14AUN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 155 / Monday, August 14, 2023 / Notices
Agenda: To review and evaluate grant
applications
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Grand Hall, 5601
Fishers Lane, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892–9834, 301–496–7291, poeky@
mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Terrace Room,
5601 Fishers Lane, Rockville, MD 20852
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Grand Hall, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid
Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892–9834, 301–496–7291, poeky@
mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council
Microbiology and Infectious Diseases
Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Garden 2, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid
Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Garden 2, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid
Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD,
20892–9834, 301–496–7291, poeky@
mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council
Immunology and Transplantation
Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
VerDate Sep<11>2014
17:38 Aug 11, 2023
Jkt 259001
55055
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Garden 1, 5601
Fishers Lane, Rockville, MD 20852.
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Garden 1, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid
Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892–9834 301–496–7291, poeky@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaid.nih.gov/about/advisory-council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Imaging
Technology Development Study Section.
Date: August 25, 2023.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 9, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Request for Letters of Interest (LOI) for
NCI-ComboMATCH Laboratories
[FR Doc. 2023–17398 Filed 8–11–23; 8:45 am]
BILLING CODE 4140–01–P
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: August 8, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–17316 Filed 8–11–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
AGENCY:
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
National Institutes of Health,
HHS.
Notice.
The National Cancer Institute
(NCI) through its National Clinical
Trials Network (NCTN) has developed a
successor precision medicine trial to
‘NCI-Molecular Analysis for Therapy
Choice (NCI–MATCH)’ entitled ‘NCIComboMATCH’. The principle of this
initiative is to overcome drug resistance
to single-agent therapy by developing
genomically-directed targeted agent
combinations. All combinations must be
supported by robust, preclinical in vivo
evidence.
SUMMARY:
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 88, Number 155 (Monday, August 14, 2023)]
[Notices]
[Pages 55054-55055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17398]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting can
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: September 11, 2023.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Acting Director.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Grand Hall, 5601
Fishers Lane, MD 20852 (Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
[[Page 55055]]
Agenda: To review and evaluate grant applications
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Grand Hall, 5601
Fishers Lane, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD 20892-9834, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Terrace Room, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Grand Hall, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD 20892-9834, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Microbiology and Infectious Diseases Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Garden 2, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Garden 2, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD, 20892-9834, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Immunology and Transplantation Subcommittee.
Date: September 11, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Garden 1, 5601
Fishers Lane, Rockville, MD 20852.
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Garden 1, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
4F50, Bethesda, MD 20892-9834 301-496-7291, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://www.niaid.nih.gov/about/advisory-council, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 9, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17398 Filed 8-11-23; 8:45 am]
BILLING CODE 4140-01-P
